Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,607.68
(
0.36%
)
US TECH 100
29,731.00
(
0.67%
)
Dow Jones
51,081.75
(
0.10%
)
Brent Oil
94.93
(
3.91%
)
Bitcoin
71,488.99
(
-2.81%
)
News Focus
News Focus
Post# of 828574
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4199
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: SkyLimit2022 post# 558733

Thursday, 01/12/2023 12:15:22 AM

Thursday, January 12, 2023 12:15:22 AM

Post# of 828574
How about the financial interest of the NWBO trial publication "corresponding author" -- how much stock does he have?? Quite a bit.

"Corresponding Author: Marnix L. Bosch, PhD, Northwest Biotherapeutics, Inc, 4800 Montgomery Ln, Bethesda, MD 20814 (marnix@nwbio.com).

Author Contributions: Dr Bosch had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis."
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News